Virbac has published sales of 1247 ME for the full year 2023, up 2.5% as reported and +4.6% at constant exchange rates and scope of consolidation.

Full-year sales were driven in particular by record fourth-quarter sales of 321 ME (+9.1% as reported and +10.6% at constant exchange rates and scope of consolidation).

Virbac confirms its sales growth target for 2024 of between 4% and 6% at constant exchange rates and scope of consolidation, as well as a ratio of operating income before amortization of assets acquired through acquisitions (adjusted Ebit) to sales of around 15% at constant exchange rates.

We reaffirm our ambition to achieve an EBITDA ratio of 20% by 2030", adds Virbac.

Copyright (c) 2024 CercleFinance.com. All rights reserved.